Earnings forecast
Consolidated earnings forecast for the fiscal year ending March 31, 2026 (April 1, 2025 to March 31, 2026)
|
Net sales
|
Operating income
|
Ordinary income
|
Profit attributable to owners of parent
|
Net income per share
|
Announced on May 13,2025
|
234,600 million yen (Increase year-on- year by 5.4%)
|
20,000 million yen (decrease year-on- year by 2.0%)
|
19,700 million yen (decrease year-on- year by 11.5%)
|
17,400 million yen (decrease year-on- year by 0.6%)
|
113.60 yen
|
The business environment surrounding the Nippon Kayaku Group faces the risk of an economic downswing due to geopolitical risks, U.S. tariff hikes, and other concerning factors.
Under these conditions, the Nippon Kayaku Group aims to respond flexibly to changes in the business envi-ronment and pursue optimal use of operating capital to increase shareholder value, as well as expand existing businesses in global growth markets, accelerate the development of new businesses and new products, and enhance profits.
In the safety systems business, we will continue to enhance the product line-up and expand sales of airbag in-flators, micro gas generators for seatbelt pretensioners, and squibs, and will continue to focus on research and development of new products that utilize explosives, a core technology.
In the Polatechno business, products under development include shades for HUDs required in vehicles, com-ponents for X-ray analysis systems used in mobile X-ray analysis systems, electron microscopes and other prod-ucts.
In the functional materials business, the products being developed include circuit boards and high-performance resins used semiconductor encapsulation in the rapidly proliferating next generation of high-speed (5G/6G) communications, AI servers, and other data center equipment in the information and commu-nications fields and the increasingly sophisticated electronic equipment in automobiles, epoxy resins used in car-bon fiber-reinforced plastics, and semiconductor cleaners and semiconductor manufacturing equipment. In the color materials business, such products include industrial inkjet ink, functional colorants for use in image sensors, and dichromatic colorants for light-controlled glass. In the catalyst business, products under development include high-yield catalysts for the manufacture of acrylic acid and methacrylic acid, which contribute to energy and re-source conservation, and green catalysts to contribute to the realization of a carbon neutral, hydrogen-based socie-ty.
In the pharmaceuticals business, we are targeting market penetration of new drugs such as PORTRAZZA®, a biomedicine for lung cancer; DARVIAS®, a drug for blood cancer; and ALAGLIO®, a photodynamic diagnostic agent. We are working to expand our product line-up in antibody biosimilars, distinctive generic drugs created through ingenuity in pharmaceutical formulations, and other products in the cancer-related areas, and to further strengthen stable supply and the quality assurance system.
In the agrochemicals business, we are focusing on expanding domestic and export sales volume for flometoquin, an insecticide, working toward the development of new unique drug formulations and new insecti-cides, and development and introduction of biostimulants.
In the consolidated fiscal year ending March 31, 2026, Nippon Kayaku forecasts a 5.4% year-on-year increase in net sales to 234,600 million yen. We forecast operating income of 20,000 million yen, a decrease of 2.0% year-on-year; ordinary income of 19,700 million yen, a decrease of 11.5% year-on-year; and profit attributable to owners of parent of 17,400 million yen, a decrease of 0.6% year-on-year.
The main exchange rate assumption for the business results forecast is JPY144/USD.
provided by StockWeather.com,Inc.